Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients

This study supports the additional prognostic value of HRQoL data at diagnosis to identify vulnerable subpopulations in elderly NSCLC patients. HRQoL could thus be valuable in selecting patients who will benefit from doublet chemotherapy.